» Articles » PMID: 11564483

Effect of Levodopa in Combination with Physiotherapy on Functional Motor Recovery After Stroke: a Prospective, Randomised, Double-blind Study

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2001 Sep 21
PMID 11564483
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Functional disability is generally caused by hemiplegia after stroke. Physiotherapy used to be the only way of improving motor function in such patients. However, administration of amphetamines in addition to exercise improves motor recovery in animals, probably by increasing the concentration of norepinephrine in the central nervous system. Our aim was to ascertain whether levodopa could enhance the efficacy of physiotherapy after hemiplegia.

Methods: We did a prospective, randomised, placebo-controlled, double-blind study in which we enrolled 53 primary stroke patients. For the first 3 weeks patients received single doses of levodopa 100 mg or placebo daily in combination with physiotherapy. For the second 3 weeks patients had only physiotherapy. We quantitatively assessed motor function every week with Rivermead motor assessment (RMA).

Findings: Six patients were excluded from analyses because of non-neurological complications. Motor recovery was significantly improved after 3 weeks of drug intervention in those on levodopa (RMA improved by 6.4 points) compared with placebo (4.1), and the result was independent of initial degree of impairment (p<0.004). The advantage of the levodopa group was maintained at study endpoint 3 weeks after levodopa was stopped. At the end of the study the total RMA score gain for the levodopa group was 8.2 points compared with 5.7 in the placebo group (p=0.020).

Interpretation: A single dose of levodopa is well tolerated and, when given in combination with physiotherapy, enhances motor recovery in patients with hemiplegia. In view of its minimal side-effects, levodopa will be a possible add- on during stroke rehabilitation.

Citing Articles

Neuroprotective effect of L-DOPA-induced interleukin-13 on striatonigral degeneration in cerebral ischemia.

Jeon E, Seo M, Lkhagva-Yondon E, Lim Y, Kim S, Kang Y Cell Death Dis. 2024; 15(11):854.

PMID: 39578419 PMC: 11584695. DOI: 10.1038/s41419-024-07252-x.


Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial.

Saporta-Wiesel L, Feldman R, Levi L, Davidson M, Burshtein S, Gur R Schizophr Bull Open. 2024; 5(1):sgae022.

PMID: 39502135 PMC: 11535855. DOI: 10.1093/schizbullopen/sgae022.


Self-organizing recruitment of compensatory areas maximizes residual motor performance post-stroke.

Lee K, Barradas V, Schweighofer N bioRxiv. 2024; .

PMID: 39005333 PMC: 11244868. DOI: 10.1101/2024.06.28.601213.


Dopaminergic mesolimbic structural reserve is positively linked to better outcome after severe stroke.

Asmussen L, Frey B, Frontzkowski L, Wrobel P, Grigutsch L, Choe C Brain Commun. 2024; 6(3):fcae122.

PMID: 38712322 PMC: 11073754. DOI: 10.1093/braincomms/fcae122.


Transcriptome-Wide 5-Methylcytosine Profiling of lncRNAs in the Mouse Cerebral Ischemia Model.

Zhang C, Gao J, Xiong D, Zhao Y Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543171 PMC: 10974612. DOI: 10.3390/ph17030384.